Field-Based Director, Specialty & Emerging Pharmacy

GlaxoSmithKline; Philadelphia (Philadelphia County); On-site; USD 150,000 - 190,000; Full time

Job summary

GlaxoSmithKline is seeking a Director, Specialty & Emerging Pharmacy Channels to lead commercial performance, pull-through execution, and strategic engagement across traditional SP and emerging digital entrants. The role reports to the FVP, Enterprise Distribution & Channel.

The position focuses on managing SP partners, REMS compliance, and analytics while building engagement frameworks for non-traditional channels and driving patient access initiatives across oncology and rare disease

Qualifications

• Bachelor's degree required.
• 10+ years of pharmaceutical commercial experience.
• 5+ years in specialty pharmacy channel management or oncology trade account management roles.
• Experience managing SP accounts at the Director- or Senior Manager-level.
• Oncology or specialty therapeutic area account management including buy-and-bill and clinical pharmacist engagement.

Responsibilities

• Own commercial field relationships with SP partners and manage pull-through and compliance.
• Execute SP performance scorecards and address gaps affecting patient access.
• Lead SP clinical pharmacist engagement in oncology and specialty areas.
• Serve as field account lead for REMS governance, certified network management, and patient enrollment support.
• Coordinate with Brand Hub, Patient Services, Payer Access, and Medical Affairs on SP workflows.

Skills

Account Management

Cross-Functional Work

Data to Insights

Digital Fluency

Omnichannel

Scientific Literacy

Education

Bachelor's degree

Job description

GlaxoSmithKline is seeking a Director, Specialty & Emerging Pharmacy Channels to lead commercial performance, pull-through execution, and strategic engagement across traditional SP and emerging digital entrants. The role reports to the FVP, Enterprise Distribution & Channel.

The position focuses on managing SP partners, REMS compliance, and analytics while building engagement frameworks for non-traditional channels and driving patient access initiatives across oncology and rare disease